CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: risk assessment
Dong Il Park, Tadakazu Hisamatsu, Minhu Chen, Siew Chien Ng, Choon Jin Ooi, Shu Chen Wei, Rupa Banerjee, Ida Normiha Hilmi, Yoon Tae Jeen, Dong Soo Han, Hyo Jong Kim, Zhihua Ran, Kaichun Wu, Jiaming Qian, Pin-Jin Hu, Katsuyoshi Matsuoka, Akira Andoh, Yasuo Suzuki, Kentaro Sugano, Mamoru Watanabe, Toshifumi Hibi, Amarender S. Puri, Suk-Kyun Yang
Intest Res. 2018;16(1):4-16.   Published online January 18, 2018
DOI: https://doi.org/10.5217/ir.2018.16.1.4

Excel Download

Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: risk assessment
Intestinal Research. 2018;16(1):4   Crossref logo
Link1 Link2 Link3

Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: management
Intestinal Research. 2018;16(1):17   Crossref logo
Link1 Link2 Link3

Asian Organization for Crohn's and Colitis and Asian Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: Risk assessment
Journal of Gastroenterology and Hepatology. 2017;33(1):20-29   Crossref logo
Link1 Link2

Risk of Attenuated Live Vaccines-Induced Infections in Infants of Mothers Receiving Anti-Tumor Necrosis Factor Agents for Inflammatory Bowel Disease
Gastroenterology. 2016;151(6):1250   Crossref logo
Link1 Link2

Risk of Serious Infection
Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease. ;147-151   Crossref logo
Link1 Link2

Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: Management
Journal of Gastroenterology and Hepatology. 2017;33(1):30-36   Crossref logo
Link1 Link2

Diagnosis and Treatment of Latent Tuberculosis Infection in Patients with Inflammatory Bowel Diseases due to Initiation of Anti-Tumor Necrosis Factor Therapy
Intestinal Research. 2014;12(1):12   Crossref logo
Link1

Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease
Gastroenterology. 2017;153(4):1163-1164   Crossref logo
Link1 Link2

Sa1119 Clinical Features of Active Tuberculosis Developed During Anti-Tumor Necrosis Factor-α Therapy in Patients With Inflammatory Bowel Diseases
Gastroenterology. 2015;148(4):S-231   Crossref logo
Link1 Link2

Exam 1: Risks of Serious Infection or Lymphoma With Anti–Tumor Necrosis Factor Therapy for Pediatric Inflammatory Bowel Disease: A Systematic Review
Clinical Gastroenterology and Hepatology. 2014;12(9):e87-e89   Crossref logo
Link1 Link2